share_log
Breakings ·  Dec 12 21:00
D. Boral Capital Served as Co-Manager to Immunitybio, Inc. (Nasdaq: Ibrx) in Connection With Its $100.0 Million Underwritten Public Offering
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment